U.S. Stock Futures Slide as Tech Rout Deepens on Amazon Capex Shock 
Stuck in a creativity slump at work? Here are some surprising ways to get your spark back 
Canada’s local food system faces major roadblocks without urgent policy changes 
Uber Ordered to Pay $8.5 Million in Bellwether Sexual Assault Lawsuit 
SoftBank Shares Slide After Arm Earnings Miss Fuels Tech Stock Sell-Off 
Global PC Makers Eye Chinese Memory Chip Suppliers Amid Ongoing Supply Crunch 
6 simple questions to tell if a ‘finfluencer’ is more flash than cash 
FDA Targets Hims & Hers Over $49 Weight-Loss Pill, Raising Legal and Safety Concerns 
Asian Stocks Slip as Tech Rout Deepens, Japan Steadies Ahead of Election 
Vietnam’s Trade Surplus With US Jumps as Exports Surge and China Imports Hit Record 
CK Hutchison Launches Arbitration After Panama Court Revokes Canal Port Licences 
Oil Prices Slip as U.S.-Iran Talks Ease Middle East Tensions 
The pandemic is still disrupting young people’s careers 
Nvidia, ByteDance, and the U.S.-China AI Chip Standoff Over H200 Exports 
Every generation thinks they had it the toughest, but for Gen Z, they’re probably right 
Toyota’s Surprise CEO Change Signals Strategic Shift Amid Global Auto Turmoil 
Singapore Budget 2026 Set for Fiscal Prudence as Growth Remains Resilient 
BioNTech SE, a Mainz-based German biotech firm, confronts a homegrown lawsuit seeking compensation for purported COVID-19 vaccine side effects. The initial case, scheduled for court on June 12, is expected to precipitate nationwide litigation.
BioNTech is set to attend the first court hearing on Monday, June 12. It will go to court to defend itself from the first case filed by a German woman who allegedly suffered from side effects after receiving her COVID-19 jab. She is seeking damages, and more cases are expected to be filed across the country after this.
According to Reuters, the plaintiff is suing the biotech firm and asking for at least €150,000 or about $161,500 in damages. The regional court in Hamburg said that in her lawsuit, the woman said the amount is for bodily harm and other material damages that were not specified.
For this case, she is being represented by Rogert & Ulbrich law firm. She claimed that after the jab, she suffered from pains in the upper part of her body, developed a sleeping disorder, fatigue, and swollen extremities. Her lawyer, Tobias Ulbrich, told the publication that will challenge the assessment made by European Union regulators and the vaccine assessment bodies in Germany that said the BioNTech vaccine has positive benefits.
In any case, it was mentioned that under German pharmaceutical law, drug or vaccine makers are only liable to give compensation for side effects if medical science shows that their products bear incorrect information or have caused disproportionate harm commensurate to their benefits.
With this, BioNTech believes that after a careful review and consideration of the case, it concluded that the lawsuit holds no merit. It also noted that the same vaccine was already received by some 1.5 billion people around the world, including more than 64 million Germans.
Meanwhile, despite BioNTech’s statements, Financial Times reported that the law firm representing the woman insisted that the burden of proof and the possible compensation is lower in Germany. Thus, it is confident that their case against BioNTech is strong.
Photo: Mat Napo/Unsplash
